160 Research Papers Supporting Vaccine/Autism CausationGinger Taylor, MS2/9/2021
Mainstream research has found that vaccines and their ingredients can cause theunderlying medical conditions that committed physicians and researchers are commonlyfinding in children who have been given an autism diagnosis. These conditions includegastrointestinal damage, immune system impairment, chronic infections, mitochondrialdisorders, autoimmune conditions, neurological regression, glial cell activation,interleukin-6 secretion dysregulation, brain inflammation, loss of integrity of the blood–brain barrier, seizures, synaptic dysfunction, dendritic cell dysfunction, mercurypoisoning, aluminum toxicity, gene activation and alteration, glutathione depletion,impaired methylation, oxidative stress, impaired thioredoxin regulation, mineraldeficiencies, impairment of the opioid system, endocrine dysfunction, cellular apoptosis,and other disorders.PDF available
.
1.
Increased risk of developmental neurologic impairment after high exposure tothimerosal-containing vaccine in first month of life.Division of Epidemiology and Surveillance, Vaccine Safety and DevelopmentBranch, National Immunization Program, Centers for Disease Control andPrevention. 1999.Thomas M. Verstraeten, Robert Davis, David Gu, Frank DeStefanoBackground: Concern has risen on the presence of the ethylmercury containingpreservative thimerosal in vaccines. We assessed the risk for neurologic andrenal impairment associated with past exposure to thimerosal-containing vaccineusing automated data from the Vaccine Safety Data link (VSD). VSD is a largelinked database from four health maintenance organizations in Washington,Oregon and California, containing immunization, medical visit and demographicdata on over 400,000 infants born between '91 and '97.Methods: We categorized the cumulative ethylmercury exposure from Thimerosalcontaining vaccines after one month of life and assessed the subsequent risk ofdegenerative and developmental neurologic disorders and renal disorders beforethe age of six. We applied proportional hazard models adjusting for HMO, year of birth, and gender, excluding premature babies.Results: We identified 286 children with degenerative and 3702 withdevelopmental neurologic disorders, and 310 with renal disorders. The relativerisk (RR) of developing a neurologic development disorder was 1.8 ( 95%confidence intervals [CI] =1.1-2.8) when comparing the highest exposure groupat 1 month of age (cumulative dose> 25 ug) to the unexposed group.
Within thisgroup we also found an elevated risk for the following disorders: autism(RR 7.6, 95% Cl = 1.8-31.5)
, non organic sleep disorders (RR 5.0, 95% Cl = 1.6-15.9}, and speech disorders (RR 2.1, 95% (1=1.1-4.0). For the neurologicdegenerative and renal disorders group we found no significantly increased riskor a decreased risk.
En la que confían más de 1 millón de miembros
Prueba Scribd GRATIS durante 30 días para acceder a más de 125 millones de títulos sin anuncios ni interrupciones.
Comenzar prueba gratisPuede cancelar en cualquier momento.
No hay comentarios:
Publicar un comentario